DALLAS, Texas -- Biometric Signature ID ("BSI") announces that CEO, Jeffrey Maynard, will be a speaker at 2007 InnoTech Austin, the Business & Technology Innovation Conference & Expo to take place at the Austin Convention Center. Mr. Maynard will speak Thursday, October 11 at 9:00 a.m. with an innovative presentation entitled "Biometric Solutions for Identity Authentication and Identity Theft - What You Should Know."

ATLANTA, Ga. -- M2SYS Technology, a leading biometric technology research and development firm, announced today its partnership with TeraCorp Enterprises, a leading provider of check cashing and verification solutions, to integrate the M2SYS Bio-Plugin(TM) fingerprint solution into TeraCash, a cutting-edge check cashing system.

ATLANTA, Ga. -- M2SYS Technology, an award-winning biometric technology research and development firm, announced today that they have partnered with Gnosis Medical Services to provide a biometric fingerprint solution for patient identification in developing countries.

SANTA CLARA, Calif. -- SecuGen, a world leading optical fingerprint recognition technology company, announced today its partnership with M2SYS Technology, a biometric technology research and development firm, to support their award winning Bio-Plugin(TM) software that allows software developers to rapidly integrate a complete, server-based, turn-key fingerprint software system with hardly any development effort.

ATLANTA, Ga. -- M2SYS Technology, a biometric technology research and development firm, announced today its partnership with SecuGen Corporation to support their revolutionary fingerprint reader, the Hamster Plus. The Hamster Plus fingerprint reader features innovative Auto-On technology that automatically checks for the presence of a finger.

ATLANTA, Ga. -- M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that Stromberg, a subsidiary of Paychex, Inc. (NASDAQ:PAYX), and a leading provider of time and attendance solutions for mid- to large-sized businesses, has integrated M2SYS' Bio-SnapON(TM) solution into their Web-enabled time and attendance software.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that an advanced Phase I/II clinical trial using intravenous Rexin-G(TM) for pancreatic cancer that is refractory to standard chemotherapy will open in the summer of 2007 in Los Angeles, California. Rexin-G is the world's first tumor-targeted injectable gene delivery system that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.

ATLANTA, Ga. -- M2SYS, an award-winning biometric technology research and development firm announced today that LunchByte Systems, Inc., home of the NUTRIKIDS brand of foodservice management solutions, has integrated M2SYS' unique Bio-SnapON(TM) solution into their lunchline POS system; instantly increasing the security and efficiency of their application.

PASADENA, Calif. -- Osmetech plc (LSE, AIM; OMH) today announced that it has granted a non-exclusive research license to Waltham, Massachusetts, US-based Minerva Biotechnologies Corporation ("Minerva") for use of Osmetech's self-assembling monolayer (SAM) technology in conjunction with Minerva's proprietary nanoparticle technology. Osmetech is a fast developing, international molecular diagnostics business.

FRESNO, Calif. -- Cypress Systems, Inc, a Fresno CA based biotechnology company, announced that it has hired Mark Whitacre, Ph.D. Dr. Whitacre joined the executive management team effective January 1, 2007 as COO & President, Technology and Business Development, following the opening of a new office in Pensacola, Florida in December, 2006.